Arcas
Arcas is a precision oncology therapeutics platform that leverages artificial intelligence, multi-omics, and pharmacological data to develop and deliver personalized cancer therapies. The platform integrates clinical, genomic, and pharmacological data using a multi-level deep learning approach to enable predictive pre-clinical drug screening and more precise biomarkers for clinical trials, resulting in more accurate companion diagnostics. Supported by the Berlin Institute of Health and Max Delbrück Center for Molecular Medicine, Arcas aims to reduce costs and timelines in oncology drug development while improving treatment precision and patient outcomes.
Arcas
Arcas is a precision oncology therapeutics platform that leverages artificial intelligence, multi-omics, and pharmacological data to develop and deliver personalized cancer therapies. The platform integrates clinical, genomic, and pharmacological data using a multi-level deep learning approach to enable predictive pre-clinical drug screening and more precise biomarkers for clinical trials, resulting in more accurate companion diagnostics. Supported by the Berlin Institute of Health and Max Delbrück Center for Molecular Medicine, Arcas aims to reduce costs and timelines in oncology drug development while improving treatment precision and patient outcomes.